Syncope in hypertrophic cardiomyopathy (part II): An expert consensus statement on the diagnosis and management

Int J Cardiol. 2023 Jan 1:370:330-337. doi: 10.1016/j.ijcard.2022.10.153. Epub 2022 Oct 26.

Abstract

Syncopal events in patients with hypertrophic cardiomyopathy (HCM) are of concern as they are a vital consideration in algorithms for risk stratification for sudden cardiac death (SCD) and ICD implantation. However, the cause of syncope is often under-investigated and/or unexplained. Current syncope guidelines do not provide a detailed definition of unexplained syncope. To address this important gap, an international panel of experts in the field of both syncope and HCM wrote a consensus document with the aim of providing practical guidance for the diagnosis and management of syncope in patients with HCM.

Keywords: Diagnosis; Hypertrophic cardiomyopathy; Implantable defibrillator; Reflex syncope; Risk stratification; Sudden cardiac death; Syncope.

Publication types

  • Review

MeSH terms

  • Cardiomyopathy, Hypertrophic* / complications
  • Cardiomyopathy, Hypertrophic* / diagnosis
  • Cardiomyopathy, Hypertrophic* / therapy
  • Death, Sudden, Cardiac / epidemiology
  • Death, Sudden, Cardiac / etiology
  • Death, Sudden, Cardiac / prevention & control
  • Defibrillators, Implantable* / adverse effects
  • Humans
  • Risk Assessment
  • Risk Factors
  • Syncope / diagnosis
  • Syncope / etiology
  • Syncope / therapy